North America Biotechnology Market, By Product Type (Instruments, Reagents And Services & Software), Technology (Nano Biotechnology, PCR Technology, DNA Sequencing, Chromatography, Tissue Engineering And Regeneration, Cell-Based Assays, Fermentation And Others), Application (Bio-pharmacy, Bio-industrial, Bio-services, Bioinformatics And Bio-agriculture), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes And Others), Distribution Channel (Direct Tender, Third Party Distributors, And Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast To 2028.
Market Analysis and Insights: North America Biotechnology Market
The biotechnology market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 27.9% in the forecast period of 2021 to 2028 and is expected to reach USD 2,691,409.16 million by 2028. Rising prevalence of chronic diseases demands the advanced biotechnology products and instruments which is acts as driver for the biotechnology market growth.
Biotechnology is a technology that utilizes biological systems, living organisms, or parts of this to develop or create different products. Brewing and baking bread are instances of processes that fall within the concept of biotechnology (use of yeast (living organism) to produce the desired product). Such traditional processes usually utilize the living organisms in their natural form (or further developed by breeding), while the more modern form of biotechnology will generally involve a more advanced modification of the biological system or organism. Today, biotechnology covers many different disciplines (for instances genetics, biochemistry, and molecular biology, among others). New technologies and products are developed every year within the areas of medicine (development of new medicines and therapies), agriculture (development of genetically modified plants, biofuels, biological treatment), or industrial biotechnology (production of chemicals, paper, textiles, and food).
The biotechnology market is growing due to the increased incidence of chronic diseases and the rise in technological advancement. Moreover, an increasing number of product approval is another factor that accelerating the biotechnology market growth. Lack of skilled professionals is expected to restraint the global biotechnology market growth.
The biotechnology market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the biotechnology market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Biotechnology Market Scope and Market Size
The biotechnology market is segmented on the based on the product type, technology, application, end user and distribution channel. The growth among segments helps you analyses niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the biotechnology market is segmented into instruments, reagents and services & software. In 2021, the instruments segment is expected to dominate the biotechnology market due to the availability of a diverse range of innovative solutions.
- On the basis of technology, the biotechnology market is segmented into nanobiotechnology, PCR technology, DNA sequencing, chromatography, tissue engineering and regeneration, cell-based assays, fermentation, and others. In 2021, the nanobiotechnology segment is expected to dominate the biotechnology market due to its broad range of applications.
- On the basis of application, the biotechnology market is segmented into bio-pharmacy, bio-industrial, bio-services, bioinformatics and bio-agriculture. In 2021, bio-pharmacy segment is expected to dominate the biotechnology market due to the rising number of research and development activities.
- On the basis of end user, the biotechnology market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic & research institutes and others. In 2021, the pharmaceutical & biotechnology companies segment is expected to dominate the biotechnology market due to increasing initiative activities by various healthcare organizations and government bodies to encourage research endeavors.
- On the basis of distribution channel, the biotechnology market is segmented into direct tender, third party distributors, and others. In 2021, the direct tender segment is expected to dominate the biotechnology market due to the rising demand for biotechnology instruments.
Biotechnology Market Country Level Analysis
The biotechnology market is analyzed and market size information is provided by the country, product type, technology, application, end user and distribution channel as referenced above.
The countries covered in the biotechnology market report are the U.S., Canada and Mexico.
- In North America, the U.S. is expected to dominate the market due to rising number of biotechnology instrument approval by FDA.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Biotechnology, is Boosting the Market Growth
The biotechnology market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Biotechnology Market Share Analysis
Biotechnology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to biotechnology market.
The major companies which are dealing in the biotechnology are Trinity Biotech, Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd, Charles River Laboratories, Eurofins Scientific, Promega Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Takara Bio Inc., Ortho Clinical Diagnostics, QIAGEN, Agilent Technologies, Inc., AstraZeneca, Merck KGaA, bioMérieux SA, Myriad Genetics, Inc., Illumina, Inc., Pacific Biosciences of California, Inc. and Biogen among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the biotechnology market.
For instance,
- In February 2021, Thermo Fisher Scientific Inc. has announced it has completed its previously announced acquisition of Mesa Biotech, Inc. This acquisition anticipated to strengthen company’s leadership in biotechnology market.
- In March 2021, Charles River Laboratories has announced that it has acquired Retrogenix Limited, an early-stage contract research organization (CRO) providing specialized bioanalytical services utilizing its proprietary cell microarray technology. This acquisition anticipated strengthen company’s bioanalytical business sector.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company footprints in the biotechnology market which also provides the benefit for organization’s profit growth.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA BIOTECHNOLOGY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 NORTH AMERICA BIOTECHNOLOGY MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING GERIATRIC POPULATION
5.1.2 GROWING PREVALENCE OF CHRONIC DISEASES
5.1.3 INCREASING TECHNOLOGICAL ADVANCEMENTS
5.1.4 WIDE RANGE OF APPLICATION
5.1.5 RISING FUNDING AND INVESTMENTS FOR THE DEVELOPMENT OF BIOTECHNOLOGY TECHNIQUES
5.2 RESTRAINTS
5.2.1 GROWING PACE OF PRODUCT RECALL
5.2.2 HIGH COST OF BIOTECHNOLOGY INSTRUMENT
5.2.3 STRICT REGULATORY FRAMEWORK
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MAJOR MARKET PLAYERS
5.3.2 ESCALATION IN INNOVATION AND TECHNOLOGIES
5.3.3 RISING EXPENDITURE ON HEALTHCARE
5.4 CHALLENGES
5.4.1 SHORTAGE OF SKILLED PERSONNEL
5.4.2 LIMITATIONS OF DOWNSTREAM PURIFICATION
6 IMPACT OF COVID-19 ON THE NORTH AMERICA BIOTECHNOLOGY MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 STRATEGIC DECISIONS BY MANUFACTURERS
6.5 CONCLUSION
7 NORTH AMERICA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 INSTRUMENT
7.3 REAGENTS
7.4 SERVICES & SOFTWARE
8 NORTH AMERICA BIOTECHNOLOGY MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 NANO BIOTECHNOLOGY
8.3 NANOCRYSTALS
8.4 NANOPARTICLES
8.5 LIPOSOMES
8.6 MICELLES
8.7 OTHERS
8.8 PCR TECHNOLOGY
8.9 CONVENTIONAL PCR
8.1 REAL-TIME PCR (QPCR)
8.11 DIGITAL PCR (DPCR)
8.12 REVERSE TRANSCRIPTION PCR (RT-PCR)
8.13 OTHER PCR
8.14 DNA SEQUENCING
8.15 SEQUENCING BY SYNTHESIS
8.16 ION SEMICONDUCTOR SEQUENCING
8.17 SEQUENCING BY LIGATION
8.18 PYROSEQUENCING
8.19 SINGLE MOLECULE REAL-TIME SEQUENCING
8.2 CHAIN TERMINATION SEQUENCING
8.21 NANOPORE SEQUENCING
8.22 CHROMATOGRAPHY
8.23 GAS CHROMATOGRAPHY
8.24 LIQUID CHROMATOGRAPHY
8.25 THIN LAYER CHROMATOGRAPHY
8.26 SUPERCRITICAL FLUID CHROMATOGRAPHY
8.27 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY/ULTRA HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC/UHPLC)
8.28 AFFINITY CHROMATOGRAPHY
8.29 TISSUE ENGINEERING AND REGENERATION
8.3 IMMUNOISOLATION TECHNOLOGY
8.31 CELL CULTURE TECHNOLOGY
8.32 STEM CELL TECHNOLOGY
8.33 CELL-BASED ASSAYS
8.34 FLOW CYTOMETRY
8.35 AUTOMATED HANDLING
8.36 LABEL-FREE-DETECTION
8.37 HIGH-THROUGHPUT SCREENING
8.38 OTHERS
8.39 FERMENTATION
8.4 UPSTREAM PROCESS
8.41 DOWNSTREAM PROCESS
8.42 OTHERS
9 NORTH AMERICA BIOTECHNOLOGY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BIOPHARMACY
9.3 BIOINDUSTRIAL
9.4 BIOSERVICES
9.5 BIOINFORMATICS
9.6 BIOAGRICULTURE
10 NORTH AMERICA BIOTECHNOLOGY MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 CONTRACT RESEARCH ORGANIZATIONS
10.4 ACADEMIC & RESEARCH INSTITUTES
10.5 OTHERS
11 NORTH AMERICA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 NORTH AMERICA BIOTECHNOLOGY MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA BIOTECHNOLOGY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 F. HOFFMANN-LA ROCHE LTD
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ASTRAZENECA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 MERCK KGAA
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 ABBOTT
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BIOGEN
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BIOMÉRIEUX SA
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIO-RAD LABORATORIES, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 CHARLES RIVER LABORATORIES
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 EUROFINS SCIENTIFIC
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 ILLUMINA, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 MYRIAD GENETICS, INC.
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 ORTHO CLINICAL DIAGNOSTICS.
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS
15.15 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 PERKINELMER INC.
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 PROMEGA CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.18 TAKARA BIO INC.
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 TRINITY BIOTECH
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 QIAGEN
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA CANCER INCIDENCE IN BOTH THE GENDERS (2018)
TABLE 2 NORTH AMERICA CANCER INCIDENCE IN MEN (2018)
TABLE 3 NORTH AMERICA CANCER INCIDENCE IN WOMEN (2018)
TABLE 4 NORTH AMERICA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA INSTRUMENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA REAGENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA SERVICES & SOFTWARE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA FERMENTATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA BIOPHARMACY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA BIOINDUSTRIAL IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA BIOSERVICES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA BIOINFORMATICS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA BIOAGRICULTURE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA DIRECT TENDER IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 NORTH AMERICA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 U.S. BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 53 U.S. BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 54 U.S. FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 55 U.S. TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 56 U.S. PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 57 U.S. NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 58 U.S. CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 59 U.S. DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 60 U.S. CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 61 U.S. BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 62 U.S. BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 63 U.S. BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 CANADA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 65 CANADA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 CANADA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 67 CANADA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 68 CANADA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 69 CANADA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 70 CANADA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 71 CANADA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 72 CANADA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 73 CANADA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 CANADA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 75 CANADA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 76 MEXICO BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 77 MEXICO BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 78 MEXICO FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 79 MEXICO TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 80 MEXICO PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 81 MEXICO NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 MEXICO CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 83 MEXICO DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 84 MEXICO CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 85 MEXICO BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 MEXICO BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 MEXICO BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA BIOTECHNOLOGY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA BIOTECHNOLOGY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA BIOTECHNOLOGY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA BIOTECHNOLOGY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA BIOTECHNOLOGY MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA BIOTECHNOLOGY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA BIOTECHNOLOGY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA BIOTECHNOLOGY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA BIOTECHNOLOGY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA BIOTECHNOLOGY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GROWING PREVALENCE OF CHRONIC DISEASES IS DRIVING THE NORTH AMERICA BIOTECHNOLOGY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 INSTRUMENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA BIOTECHNOLOGY MARKET IN 2021 & 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA BIOTECHNOLOGY MARKET
FIGURE 16 CANCER DEATH RATES BY AGE GROUP (2017)
FIGURE 17 NUMBER OF NEW CANCER CASES FOR ALL AGE GROUPS (IN 2018)
FIGURE 18 NUMBER OF NEW CASES IN MALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 19 NUMBER OF NEW CASES IN FEMALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 20 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2020
FIGURE 21 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 22 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 23 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 NORTH AMERICA BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2020
FIGURE 25 NORTH AMERICA BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2021-2028 (USD MILLION)
FIGURE 26 NORTH AMERICA BIOTECHNOLOGY MARKET : BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 27 NORTH AMERICA BIOTECHNOLOGY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 28 NORTH AMERICA BIOTECHNOLOGY MARKET : BY APPLICATION, 2020
FIGURE 29 NORTH AMERICA BIOTECHNOLOGY MARKET : BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 30 NORTH AMERICA BIOTECHNOLOGY MARKET : BY APPLICATION, CAGR (2021-2028)
FIGURE 31 NORTH AMERICA BIOTECHNOLOGY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 NORTH AMERICA BIOTECHNOLOGY MARKET: BY END USER, 2020
FIGURE 33 NORTH AMERICA BIOTECHNOLOGY MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 34 NORTH AMERICA BIOTECHNOLOGY MARKET: BY END USER, CAGR (2021-2028)
FIGURE 35 NORTH AMERICA BIOTECHNOLOGY MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 NORTH AMERICA BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 37 NORTH AMERICA BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 38 NORTH AMERICA BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 39 NORTH AMERICA BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 NORTH AMERICA BIOTECHNOLOGY MARKET: SNAPSHOT (2020)
FIGURE 41 NORTH AMERICA BIOTECHNOLOGY MARKET: BY COUNTRY (2020)
FIGURE 42 NORTH AMERICA BIOTECHNOLOGY MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 NORTH AMERICA BIOTECHNOLOGY MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 45 NORTH AMERICA BIOTECHNOLOGY MARKET: COMPANY SHARE 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.